4Suppliers
3Customers
3Debt Items
20Related Chains

Verrica Pharmaceuticals Inc. Suppliers

TickerNameConfidenceEvidence
FUNING-COUNTY-DEVELOPMENT-BRUCEA-JAVANICA-PROFES FUNING-COUNTY-DEVELOPMENT-BRUCEA-JAVANICA-PROFES 92% On July 16, 2018, we entered into a Supply Agreement, or the Supply Agreement, with Funing County Development Brucea Javanica Professional Cooperatives, or the Supplier, pursuant to which the Supplie…
LYTIX-BIOPHARMA-ASA LYTIX-BIOPHARMA-ASA 90% The Company entered into an exclusive license agreement with Lytix Biopharma ASA ("Lytix") for the use of licensed technology, referred to as VP-315, to research, develop, manufacture, have manufactu…
ORANY ORANY 72% ’s Republic of China. On July 16, 2018, we entered into a Supply Agreement, or the Supply Agreement, with Funing County Development Brucea Javanica Professional Cooperatives, or the Supplier, pursuan…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from VRCA graph: ’s Republic of China. On July 16, 2018, we entered into a Supply Agreement, or the Supply Agreement, with Funing Cou…

Verrica Pharmaceuticals Inc. Customers

TickerNameConfidenceEvidence
TORII TORII 92% The Company grants Torii an exclusive license to develop and commercialize the Company's product candidates that contain a topical formulation of cantharidin for the treatment of molluscum contagiosu…
ORANY ORANY 72% ’s Republic of China. On July 16, 2018, we entered into a Supply Agreement, or the Supply Agreement, with Funing County Development Brucea Javanica Professional Cooperatives, or the Supplier, pursuan…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from VRCA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from VRCA graph: ’s Republic of China. On July 16,…

Verrica Pharmaceuticals Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
VRCA-DEBT-13420 Warrants outstanding: 95.6 90% xbrl warrant detail from xbrl 2024-05-14.
VRCA-DEBT Debt stack $1.4M 90% Market cache reports total debt of $1.4M.
VRCA-DEBT-13421 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Verrica Pharmaceuticals Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Verrica Pharmaceuticals Inc..

Verrica Pharmaceuticals Inc. Ownership

HolderNameConfidenceEvidence
VRCA-OWNER-CALIGAN-PARTNERS-LP Caligan Partners LP 90% 13F overlay lists Caligan Partners LP as top holder; 42 tracked holders.

Verrica Pharmaceuticals Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer', 'supplier']
TORII TORII 63.48 1 ['receiving']
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2